A proteomic approach in the study of an animal model of Parkinson's disease

Clinica Chimica Acta

Volumn 357, Issue 2, 2005, Pages 202-209

  De Iuliis, Angela ^a   Grigoletto, Jessica ^a   Recchia, Alessandra ^a   Giusti, Pietro ^a   Arslan, Paola ^a  

^a UNIVERSITY OF PADOVA   (Italy)

Author keywords

Neurodegenerative mechanism; Parkinson's disease; Protein oxidation; Proteomics

Indexed keywords

ALPHA ENOLASE; BETA ACTIN; BETA ENOLSAE; BRAIN EXTRACT; BUFFER; ENOLASE; NEUROTOXIN; OXIDOPAMINE; UNCLASSIFIED DRUG; UREA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN HOMOGENATE; BRAIN TISSUE; CATECHOLAMINERGIC SYSTEM; COMPUTER PROGRAM; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINERGIC NERVE CELL; EXPERIMENTAL MODEL; INTERMETHOD COMPARISON; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NERVE CELL NECROSIS; NEUROPATHOLOGY; NONHUMAN; PARKINSON DISEASE; PARKINSONISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEOMICS; RAT; SOLUBILIZATION; STRIATONIGRAL DEGENERATION; SUBSTANTIA NIGRA; TISSUE HOMOGENATE; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; BRAIN; DISEASE MODELS, ANIMAL; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HYDROGEN-ION CONCENTRATION; PARKINSON DISEASE; PROTEOMICS; RATS;

ANIMALIA;

EID: 21244475585     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2005.03.028     Document Type: Article

References (49)

1. C.W. Olanov, and W.G. Tatton Etiology and pathogenesis of Parkinson's disease Annu Rev Neurosci 22 1999 123 144
2. E. Bossy-Wetzel, R. Schwarzenbacher, and S.A. Lipton Molecular pathways to neurodegeneration Nat Med 10 2004 S2 S9 [Suppl.]
3. P. Jenner Oxidative stress in Parkinson's disease Ann Neurol 53 2003 26 36
4. A. De Iuliis, A. Burlina, R. Boschetto, P. Zambenedetti, P. Arslan, and L. Galzigna Increased dopamine peroxidation in post-mortem parkinsonian brain Biochim Biophys Acta 1573 2002 63 67
5. J. Lotharius, and P. Brundin Pathogenesis of Parkinson's disease: dopamine, vesicles and alpha-synuclein Nat Rev Neurosci 3 2002 932 942
6. G. Gille, S.T. Hung, H. Reichmann, and W.D. Rausch Oxidative stress to dopaminergic neurons as models of Parkinson's disease Ann NY Acad Sci 1018 2004 533 540
7. G. Fiskum, A. Starkov, B.M. Polster, and C. Chinopoulos Mitochondrial mechanisms of neural cell death and neuroprotective interventions in Parkinson's disease Ann NY Acad Sci 991 2003 111 119
8. N. Vanacore, A. Nappo, M. Gentile, A. Brustolin, S. Palange, and A. Liberati Evaluation of risk of Parkinson's disease in a cohort of licensed pesticide Neurol Sci 23 Suppl 2 2002 S119 S120
9. J.M. Gorell, B.A. Rybicki, C. Cole Johnson, and E.L. Peterson Occupational metal exposures and the risk of Parkinson's disease Neuroepidemiology 18 1999 303 308
10. M. Paolini, A. Sapone, and F.J. Gonzalez Parkinson's disease, pesticides and individual vulnerability Trends Pharmacol Sci 25 2004 124 129
11. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, and A. Dutra Mutation in the alpha-synuclein gene identified in families with Parkinson's disease Science 276 1997 2045 2047
12. A. Recchia, P. Debetto, A. Negro, D. Guidolin, S.D. Skaper, and P. Giusti Alpha-synuclein and Parkinson's disease FASEB J 18 2004 617 626
13. E. Leroy, R. Boyer, G. Auburger, B. Leube, G. Ulm, and E. Mezey The ubiquitin pathway in Parkinson's disease Nature 1998 39 42
14. T. Kitada, S. Asakawa, N. Hattori, H. Matsumine, Y. Yamamura, and S. Minoshima Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism Nature 392 1998 605 608
15. R. von Coelln, V.L. Dawson, and T. Dawson Parkin-associated Parkinson's disease Cell Tissue Res. 318 2004 175 184
16. V. Bonifati, P. Rizzu, M.J. van Baren, O. Schaap, G.J. Breedveld, and E. Krieger Mutations in the DJ-1 gene associated with autosomal recessive early-onset parkinsonism Science 299 2003 256 259
17. E.M. Valente, P.M. Abou-Sleiman, V. Caputo, M.M. Muqit, K. Harvey, and S. Gispert Hereditary early-onset Parkinson's disease caused by mutations in PINK1 Science 304 2004 1158 1160
18. H. Shimura, M.G. Schlossmacher, N. Hattori, M.P. Frosch, A. Trockebacher, and R. Schneider Ubiquitination of a new form of alpha-synuclein by parkin from human brain: implications for Parkinson's disease Science 293 2001 263 269
19. R.M. Canet-Aviles, M.A. Wilson, D.W. Miller, R. Ahmad, C. McLendon, and S. Bandyopadhyay The Parkinson's disease protein DJ-1 is neuroprotective due to cysteine-sulfinic acid-driven mitochondrial localization Proc Natl Acad Sci 101 2004 9103 9108
20. M. Alam, and W.J. Schmidt Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats Behav Brain Res 136 2002 317 324
21. C. Perier, J. Bove, M. Vila, and S. Przedborski The rotenone model of Parkinson's disease Trends Neurosci 26 2003 345 346
22. J.T. Greenamyre, and T.G. Hastings Parkinson's-divergent causes, convergent mechanism Science 304 2004 1120 1122
23. R.L. Nissbaum, and C. Ellis Alzheimer's disease and Parkinson's disease N Engl J Med 348 2003 1356 1364
24. R. Layfield, J.R. Cavey, and J. Lowe Role of ubiquitin-mediated proteolysis in the pathogenesis of neurodegenerative disorders Ageing Res Rev 2 4 2003 343 356
25. M.F. Beal Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment J Bioenerg Biomembr 36 2004 381 386
26. H. Husi, and S.G. Grant Proteomics of the nervous system Trends Neurosci 24 2001 259 266
27. M. Fountoulakis Application of proteomics technologies in the investigation of the brain Mass Spectrom Rev 23 2004 231 258
28. M.S. Cheon, S.H. Kim, M. Fountoulakis, and G. Lubec Heart type fatty acid binding protein (H-FABP) is decreased in brains of patients with Down syndrome and Alzheimer's disease J Neural Transm Suppl 67 2003 225 234
29. M. Fountoulakis, T. Gulesserian, and G. Lubec Overexpression of C1-tetrahydrofolate synthase in fetal Down syndrome brain J Neural Transm Suppl 67 2003 85 93
30. M. Bajo, J. Fruehauf, S.H. Kim, M. Fountoulakis, and G. Lubec Proteomic evaluation of intermediary metabolism enzyme proteins in fetal Down's syndrome cerebral cortex Proteomics 2 11 2002 (Nov) 1539 1546
31. D.A. Butterfield, and D. Boyd-Kimball Proteomics analysis in Alzheimer's disease: new insights into mechanisms of neurodegeneration Int Rev Neurobiol 61 2004 159 188
32. J. Choi, M.J. Forster, S.R. McDonald, S.T. Weintraub, C.A. Carroll, and R.W. Gracy Proteomic identification of specific oxidized proteins in ApoE-knockout mice: relevance to Alzheimer's disease Free Radic Biol Med 36 2004 1155 1162
33. D.A. Butterfield Proteomics: a new approach to investigate oxidative stress in Alzheimer's disease brain Brain Res 1000 2004 1 7
34. M.Y. Lee, S.E. Park, K.C. Chung, and Y.J. OH Proteomic analysis reveals upregulation of calreticulin in murine dopaminergic neuronal cells after treatment with 6-hydroxidopamine Neurosci Lett 352 2003 17 20
35. E.C. Hirsch, G. Hoglinger, E. Rousselet, T. Breidert, K. Parain, and J. Feger Animal models of Parkinson's disease in rodents induced by toxins: an update J Neural Transm Suppl 65 2003 89 100
36. Y. Glinka, M. Gassen, and M.B. Youdim Mechanism of 6-hydroxydopamine neurotoxicity J Neural Transm Suppl 50 1997 55 66
37. A. Keller, A. Berod, M. Dussaillant, Lamande, F. Gros, and M. Lucas Coexpression of alpha and gamma enolase genes in neurons of adult rat brain J Neurosci Res 38 1994 493 504
38. S.J. Schonberger, P.F. Edgar, R. Kydd, R.L. Faull, and G.J. Cooper Proteomic analysis of the brain in Alzheimer disease: molecular phenotype of a complex disease process Proteomics 1 2000 1519 1528
39. A. Castegna, M. Aksenov, V. Thongbookerd, J.B. Klein, W.M. Pierce, and R. Booze Proteomic identification of oxidatively modified proteins in Alzheimer's disease brain: Part II. Dihydropyrimidinase-related protein 2, alpha-enolase and heat shock cognate 71 J Neurochem 82 2002 1524 1532
40. A. Castegna, V. Thongboonkerd, J.B. Klein, B. Lynn, W.R. Markesbery, and D.A. Butterfield Proteomic identification of nitrated proteins in Alzheimer's disease J Neurochem 85 2003 1394 1401
41. E. Pannese, P. Procacci, and M. Ledda Ultrastructural localization of actin in the cell body of rat spinal ganglion neurons Anat Embryol 194 1996 527 531
42. M.Y. Aksenov, M.V. Aksenova, D.A. Butterfield, J.W. Geddes, and W.R. Markesbery Protein oxidation in the brain in Alzheimer's disease Neuroscience 103 2001 373 383
43. R.L. Levine, and E.R. Stadtman Oxidative modification of protein during aging Exp Gerontol 36 2001 1495 1502
44. E.R. Stadtman Protein oxidation and aging Science 257 1992 1220 1224
45. R.S. Sohal, and R. Windruch Oxidative stress, caloric restriction and aging Science 273 1996 59 63
46. E. Floor, and M.G. Wetze Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay J Neurochem 70 1998 268 275
47. G. Berding, P. Odin, D.J. Brooks, G. Nikkhah, C. Matthies, and T. Peschel Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET Mov Disord 16 2001 1014 1022
48. A. Milzani, I. Dalledonne, G. Vailati, and R. Colombo Prolonged oxidative stress on actin Arch Biochem Biophys 339 1997 267 274
49. A. Milzani, I. Dalledonne, G. Vailati, and R. Colombo Paraquat induces actin assembly in depolymerising conditions FASEB J 11 1997 261 270